Award
Fox Chase Cancer Center 5UH3CA271230-05
Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
Recipient
Research Institute of Fox Chase Cancer Center
Award Amount
$470,000.00
Ceiling
$470,000.00
Awarded
July 23, 2026
Identifier
5UH3CA271230-05
Award for validating blood-based predictive biomarkers to assess therapeutic response in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiation therapy.
Description
This project involves validation of blood-based biomarkers for predicting therapeutic response in rectal cancer patients, funded by NIH/NCI, with a total award amount of $470,000, spanning from 2026 to 2027.